Oncternal Therapeutics, Inc. (ONCT)
USD 0.53
(-24.12%)
USD 0.53
(-24.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -32.16 Million | -36.7 Million | -26.58 Million | -17.49 Million | -16.74 Million | -39.34 Million |
| Net Income | -39.47 Million | -44.17 Million | -31.33 Million | -17.22 Million | -34.18 Million | -38.41 Million |
| Depreciation & Amortization | - | -75 Thousand | 169 Thousand | 150 Thousand | - | 46 Thousand |
| Deferred income taxes | - | - | -169 Thousand | -150 Thousand | - | - |
| Stock-based compensation | 7.5 Million | 7.43 Million | 5.87 Million | 1.55 Million | 507 Thousand | 2.19 Million |
| Change in working capital | 1.27 Million | -69 Thousand | -1.3 Million | -1.67 Million | -2.51 Million | -3.33 Million |
| Other non-cash items | -1.45 Million | 179 Thousand | 169 Thousand | -151 Thousand | 19.44 Million | 166 Thousand |
| Investing Cash Flow | 651 Thousand | -26.49 Million | - | - | 16.13 Million | 27.88 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | 16.13 Million | - |
| Investment purchases | -64.34 Million | -26.49 Million | - | - | - | -44.15 Million |
| Sales/Maturities of investments | 65 Million | - | - | - | - | 72.03 Million |
| Other Investing Activities | 651 Thousand | -26.49 Million | - | - | -2.15 Million | 72.03 Million |
| Financing Cash Flow | 1.06 Million | 9.57 Million | 617 Thousand | 114.18 Million | 15 Thousand | 23.9 Million |
| Debt repayment | - | - | - | -301 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -156 Thousand | -3000.00 | - | - | - | - |
| Common Stock Issuance | 1.22 Million | 9.58 Million | 617 Thousand | 113.87 Million | 1000.00 | 24.47 Million |
| Other Financing Activities | 1.22 Million | 9.57 Million | 617 Thousand | 606 Thousand | 14 Thousand | -569 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.76 Million | 958 Thousand | 816 Thousand | 272 Thousand | -4.76 Million | 675 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3.04 Million | -1.02 Million | -2.11 Million | -1.94 Million | 2.24 Million | -4.01 Million |
| Cash at beginning of period | 37.14 Million | 90.76 Million | 116.73 Million | 20.05 Million | 20.64 Million | 15.81 Million |
| Cash at end of period | 6.69 Million | 37.14 Million | 90.76 Million | 116.73 Million | 20.05 Million | 28.25 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -30.44 Million | -53.62 Million | -25.97 Million | 96.68 Million | -594 Thousand | 12.44 Million |
| Free Cash Flow | -32.16 Million | -36.7 Million | -26.58 Million | -17.49 Million | -16.74 Million | -39.34 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.55 Million | -8.38 Million | -39.47 Million | -9.16 Million | -9.86 Million | -8.96 Million |
| Depreciation & Amortization | - | - | - | 329 Thousand | 75 Thousand | 37 Thousand |
| Deferred income taxes | - | - | - | 112 Thousand | -75 Thousand | -37 Thousand |
| Stock-based compensation | 1.38 Million | 1.36 Million | 7.5 Million | 2.21 Million | 1.71 Million | 1.68 Million |
| Change in working capital | 1.53 Million | -135 Thousand | 1.27 Million | 869 Thousand | 2.91 Million | -1.54 Million |
| Other non-cash items | 757 Thousand | 771 Thousand | -1.45 Million | -342 Thousand | -283 Thousand | -430 Thousand |
| Investing Cash Flow | 5.8 Million | 7.22 Million | 651 Thousand | -1.8 Million | 4.65 Million | 13.85 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -6.29 Million | -10.02 Million | -64.34 Million | -11.8 Million | -15.34 Million | -15.14 Million |
| Sales/Maturities of investments | 12.1 Million | 17.25 Million | 65 Million | 10 Million | 20 Million | 29 Million |
| Other Investing Activities | 5.8 Million | 7.22 Million | 651 Thousand | -1.8 Million | 4.65 Million | 13.85 Million |
| Financing Cash Flow | - | -87 Thousand | 1.06 Million | -1000.00 | -49 Thousand | -1000.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -87 Thousand | -156 Thousand | -1000.00 | -49 Thousand | -1000.00 |
| Common Stock Issuance | - | - | 1.22 Million | -7.56 Million | 3.69 Million | 3.86 Million |
| Other Financing Activities | - | - | 1.22 Million | 7.56 Million | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 441 Thousand | 314 Thousand | -1.76 Million | -985 Thousand | -91 Thousand | 260 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.09 Million | -449 Thousand | 3.04 Million | 1.85 Million | 3 Million | -1.8 Million |
| Cash at beginning of period | 6.39 Million | 6.69 Million | 37.14 Million | 14.92 Million | 15.83 Million | 11.24 Million |
| Cash at end of period | 6.38 Million | 6.39 Million | 6.69 Million | 6.69 Million | 14.92 Million | 15.83 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | 2.58 Million | -3.54 Million | 960 Thousand |
| Net cash flow / Change in cash | -14 Thousand | -301 Thousand | -30.44 Million | -8.22 Million | -907 Thousand | 4.58 Million |
| Free Cash Flow | -5.82 Million | -7.43 Million | -32.16 Million | -6.41 Million | -5.51 Million | -9.26 Million |
600596
DRL
2876
PNGAY
NBN
SF-PC